Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Penn Medicine Discovered Novel Technique for Human Artificial Chromosomes
Researchers at the University of Pennsylvania have unveiled a pioneering method for creating human artificial chromosomes, representing a significant breakthrough in genetic engineering....
Orchard Therapeutics Introduced Breakthrough Lenmeldy™ Therapy for Early-onset Metachromatic Leukodystrophy
Orchard Therapeutics has unveiled its groundbreaking treatment, Lenmeldy™, as the first and only approved therapy designed for children afflicted with early-onset metachromatic...
Merck Develops First-in-Class WINREVAIR™ Treatment for Pulmonary Arterial Hypertension
Merck has developed WINREVAIR™ (sotatercept-csrk), a groundbreaking treatment designed for adults with pulmonary arterial hypertension (PAH). This medication aims to enhance exercise capacity, elevate WHO functional class...
Mind Medicine Developed Novel MM120 for the Treatment of Anxiety Disorder
Mind Medicine has developed a groundbreaking treatment named MM120 for generalised anxiety disorder MM120 is administered in a single dose...
UChicago Medicine Discovered First-of-its-kind Resmetirom Drug for Metabolic Liver Disease
The University of Chicago Medicine has unveiled a groundbreaking drug designed to tackle advanced metabolic dysfunction-associated steatotic liver disease...
Celltrion Developed First-of-its-kind ZYMFENTRA™ for the Treatment of Crohn's Disease
Celltrion has developed first-of-its-kind ZYMFENTRA™, a pioneering subcutaneous formulation of infliximab....
Bristol Myers Squibb Introduced Breakthrough Breyanzi ® CAR T Cell Therapy
Bristol Myers Squibb has introduced Breyanzi® as the first CAR T cell therapy designed specifically for adults facing relapsed or refractory chronic lymphocytic leukaemia...
Johnson & Johnson Discovered First-of-its-kind RYBREVANT® for the Treatment of Patients with Non-Small Cell Lung Cancer
Johnson & Johnson has introduced RYBREVANT® as a groundbreaking therapy for the initial treatment of individuals diagnosed with non-small cell lung cancer...
Iovance Biotherapeutics Developed First-of-its-Kind AMTAGVI™ for Advanced Melanoma
Iovance Biotherapeutics has developed first-of-its-kind AMTAGVI™ cell therapy for a solid tumour cancer and first treatment option for advanced melanoma....
Bayer Introduces Breakthrough Therapy BAY 2927088 for Non-Small Cell Lung Cancer
Bayer has introduced a groundbreaking therapy named BAY 2927088 for addressing adult patients afflicted with unresectable or metastatic non-small cell lung cancer...
